LH LYSE
Mexico·Clase II·III. DIAGNOSTIC AGENTS·ATYDE MÉXICO, S.A. DE C.V.·Registered June 07, 2018ESTE PRODUCTO ES UTILIZADO PARA LISAR GLÓBULOS ROJOS Y MANTENER LA MORFOLOGÍA CELULAR NECESARIA PARA ANALIZAR LAS CÉLULAS SANGUÍNEAS Y DETERMINAR LA HEMOGLOBINA. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS Y GABINETES.
THIS PRODUCT IS USED TO LYSE RED BLOOD CELLS AND MAINTAIN THE CELL MORPHOLOGY NEEDED TO ANALYZE BLOOD CELLS AND DETERMINE HEMOGLOBIN. FOR EXCLUSIVE USE IN CLINICAL LABORATORIES AND CABINETS.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- SOLUCIÓN DE LISIS DE GLÓBULOS ROJOS
- Trade Name (English)
- RED BLOOD CELL LYSIS SOLUTION
- Analysis ID
- 1438R2018 SSA
- Registration Date
- June 07, 2018
- Name (Spanish)
- ATYDE MÉXICO, S.A. DE C.V.
- Name (English)
- ATYDE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for LH LYSE (LH LYSE) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1438R2018 SSA and manufactured by ATYDE MÉXICO, S.A. DE C.V.. The device was registered on June 07, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.